Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Acetic Anhydride | HCID 7918 | — |
| Reactant | Lodazecar | HCID 65657 | — |
| Product | HCID 70505704 | HCID 70505704 | — |
Reaction Steps
A solution of 5 g of 1-[(S)-6-bromo-5-(o-chlorophenyl)-2,3-dihydro-1,3-dimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl]-3-[1,1-bis(hydroxymethyl)ethyl]urea in pyridine is treated with 4 ml of acetic anhydride, the mixture is stirred at room temperature for 1 hour, treated with water and extracted with methylene chloride. The organic phase is dried over sodium sulphate and evaporated, whereupon the residue is chromatographed on silica gel while eluting with chloroform and then recrystallized from petroleum ether. There is obtained (S)-N-[2-(acetyloxy)-1-[(acetyloxy)methyl]-1-methylethyl]-N'-[6-bromo-5-(o-chlorophenyl)-2,3-dihydro-1,3-dimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl]urea of melting point 105°-107° (decomposition); [α]25D =+33.75° (0.8 percent solution in methylene chloride).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04474777 |
|---|
| Source dataset | uspto-grants-1984_10 |
|---|
| ORD ID | ord-591f0c7d421d4b0ab5b89ded2ffa17dd |
|---|
| Source note | uspto-grants-1984_10 |
|---|